Posted on Sunday, June 26th, 2022 by MarketBeat Staff
There are now more than 50 publicly-traded companies operating in the cannabis industry. Most of these companies aren't directly growing and selling marijuana themselves, but they do stand to benefit greatly as more states legalize the sale and possession of marijuana. Some of these marijuana stocks are media companies. Others are privately studying the medical uses of marijuana. Yet others are providing tools and software for marijuana growers. As more cannabis companies file IPOs and enter the stock market, it will become increasingly difficult for investors to identify which marijuana stocks will truly benefit from the cannabis boom.
Our subscribers have begun digging through these companies, checking out their financials, business models and long-term growth prospects. They know that some "marijuana stocks" are just empty shell companies that deserve to be penny stocks, but they also recognize there are some legitimate and growing companies that truly stand to benefit from the green rush. As a group, they have added 10 different cannabis stocks to their watchlists and are actively investing in them. More than 1,400 MarketBeat subscribers are now following our top-trending cannabis company.
This slide show lists the 12 pot stocks that MarketBeat subscribers are have added to their watchlists and are actively monitoring.
#1 - Canopy Growth (TSE:WEED)
- MarketBeat Followers
- 2,818
- Market Cap
- C$1.97 billion
- Consensus Rating
- Hold
- Rating Score
- 1.8
- Ratings Breakdown
- 3 Buy Ratings, 5 Hold Ratings, 6 Sell Ratings.
- Consensus Price Target
- C$8.63 (76.7% Upside)
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.
Read More
Recent Analyst Ratings
#2 - Innovative Industrial Properties (NYSE:IIPR)
- MarketBeat Followers
- 1,766
- Market Cap
- $3.34 billion
- Consensus Rating
- Buy
- Rating Score
- 3.0
- Ratings Breakdown
- 5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- $239.00 (100.3% Upside)
Innovative Industrial Properties, Inc is a self-advised Maryland corporation focused on the acquisition, ownership and management of specialized properties leased to experienced, state-licensed operators for their regulated medical-use cannabis facilities. Innovative Industrial Properties, Inc has elected to be taxed as a real estate investment trust, commencing with the year ended December 31, 2017.
Recent Analyst Ratings
- MarketBeat Followers
- 1,554
- Market Cap
- $20.82 million
- Consensus Rating
- N/A
- Rating Score
- NaN
- Ratings Breakdown
- 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- N/A
Terra Tech Corp. cultivates, produces, and retails medical and adult use cannabis products. The company also operates medical marijuana retail and adult use dispensaries, cultivation, and production facilities in California and Nevada under the Blüm name in California and Nevada. Terra Tech Corp. was founded in 2010 and is based in Santa Ana, California.
Recent Analyst Ratings
#4 - 22nd Century Group (NASDAQ:XXII)
- MarketBeat Followers
- 1,353
- Market Cap
- $398.18 million
- Consensus Rating
- Buy
- Rating Score
- 3.0
- Ratings Breakdown
- 4 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- $6.13 (153.1% Upside)
22nd Century Group, Inc, an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies.
Read More
Recent Analyst Ratings
- MarketBeat Followers
- 1,345
- Consensus Rating
- N/A
- Rating Score
- NaN
- Ratings Breakdown
- 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- N/A
Cannabis Science, Inc, together with its subsidiaries, develops, produces, and commercializes phytocannabinoid-based pharmaceutical products primarily in the United States. The company is developing medicines for autism, blood pressure, cancer, cancer side effects, and other illnesses, as well as for general health maintenance.
Read More
Recent Analyst Ratings
#6 - OrganiGram (TSE:OGI)
- MarketBeat Followers
- 1,182
- Market Cap
- C$429.76 million
- Consensus Rating
- Hold
- Rating Score
- 2.4
- Ratings Breakdown
- 4 Buy Ratings, 2 Hold Ratings, 1 Sell Ratings.
- Consensus Price Target
- C$3.06 (123.1% Upside)
Organigram Holdings Inc, through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co, Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates.
Read More
Recent Analyst Ratings
- MarketBeat Followers
- 1,162
- Consensus Rating
- Buy
- Rating Score
- 3.0
- Ratings Breakdown
- 1 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- N/A
KushCo Holdings, Inc provides ancillary products and services to the legal cannabis and CBD industries. The firm through its subsidiaries and brands provides product quality, exceptional customer service, compliance knowledge and a local presence in serving diverse customer base. The company was founded by Dallas Imbimbo, John Kovacevich, Nicholas Kovacevich, and Jeffrey Meng on December 15, 2010 and is headquartered in Cypress, CA.
Recent Analyst Ratings
- MarketBeat Followers
- 1,065
- Market Cap
- $253.91 million
- Consensus Rating
- Hold
- Rating Score
- 2.4
- Ratings Breakdown
- 3 Buy Ratings, 4 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- $16.31 (290.3% Upside)
GrowGeneration Corp., through its subsidiaries, owns and operates retail hydroponic and organic gardening stores in the United States. It engages in the marketing and distribution of nutrients, growing media, advanced indoor and greenhouse lighting, environmental control systems, vertical benching, and accessories for hydroponic gardening, as well as other indoor and outdoor growing products.
Read More
Recent Analyst Ratings
#9 - Medical Marijuana (OTCMKTS:MJNA)
- MarketBeat Followers
- 1,057
- Consensus Rating
- N/A
- Rating Score
- NaN
- Ratings Breakdown
- 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- N/A
Medical Marijuana, Inc, an investment holding company, operates in the cannabinoid-based nutraceutical industry. It focuses on the development, sale, and distribution of hemp oil that contains naturally occurring cannabinoids, including cannabidiol (CBD) and other products containing CBD-rich hemp oil; treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products; and nonpsychoactive cannabidiol products.
Read More
Recent Analyst Ratings
#10 - Marijuana Company of America (OTCMKTS:MCOA)
- MarketBeat Followers
- 849
- Consensus Rating
- N/A
- Rating Score
- NaN
- Ratings Breakdown
- 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- N/A
Marijuana Company of America, Inc, together with its subsidiaries, develops, produces, and distributes cannabis and cannabidiol (CBD) products under the hempSMART brand name in the United States. The company offers hempSMART products comprising hempSMART Brain, a patented and formulated personal care consumer product for brain wellness; hempSMART Pain capsules for temporary relief of minor discomfort with physical activity; hempSMART Pain Cream to reduce minor discomfort and promote muscle relaxation; hempSMART Drops, a hemp CBD oil tincture drops; hempSMART Pet Drops for cats and dogs; hempSMART Face, a facial moisturizer; and hempSMART drink mix, an industrial hemp based powderized CBD drink through its web site and affiliate marketing programs.
Read More
Recent Analyst Ratings
- MarketBeat Followers
- 581
- Consensus Rating
- N/A
- Rating Score
- NaN
- Ratings Breakdown
- 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- N/A
Cannabis Sativa, Inc, through its subsidiaries, primarily provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology.
Read More
Recent Analyst Ratings
- MarketBeat Followers
- 512
- Market Cap
- $1.55 million
- Consensus Rating
- N/A
- Rating Score
- NaN
- Ratings Breakdown
- 0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- N/A
United Cannabis Corporation owns intellectual properties related to growth, production, manufacture, marketing, management, utilization, and distribution of medical marijuana and marijuana infused products in the United States. The company focuses on developing therapeutics, including Prana Bio Nutrient Medicinal products for supplement deficiencies related to the endocannabinoid system, including pain, neuropathy, arthritis, MS, IBS, autism, seizures, eczema, sleep, anxiety, head trauma, opioid dependency, and clinical endocannabinoid deficiencies; and Prana Aromatherapy Transdermal Roll-on line that provides targeted and large surface relief with combinations of aromatherapy.
Read More
Recent Analyst Ratings
